Ronshine China Holdings Ltd
F:1R7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Ronshine China Holdings Ltd
F:1R7
|
CN |
|
V
|
Versarien PLC
OTC:VRSRF
|
UK |
|
Athens Medical Center SA
F:ACS
|
GR |
|
E
|
Eastern Platinum Ltd
F:E9P1
|
CA |
|
Trakm8 Holdings PLC
F:T8H
|
UK |
|
M
|
mVISE AG
F:C1V
|
DE |
|
IT Link SA
F:IL8
|
FR |
|
S
|
Super Copper Corp
OTC:CUPPF
|
CA |
|
S
|
Shanta Gold Ltd
XBER:35S
|
GG |
|
T
|
Tanfield Group PLC
F:XS3A
|
UK |
|
T
|
Territorial Bancorp Inc
F:9TB
|
US |
|
Zanaga Iron Ore Company Ltd
F:6ZA
|
GG |
|
Sunlands Technology Group
F:S790
|
CN |
|
N
|
New China Life Insurance Company Ltd
XMUN:NCL
|
CN |
|
I
|
Innovent Biologics Inc
F:6IB
|
CN |
|
Euglena Co Ltd
F:8EG
|
JP |
|
Surge Copper Corp
OTC:SRGXF
|
CA |
|
Riba Mundo Tecnologia SA
F:YR2
|
ES |
|
A
|
Ambu A/S
F:547A
|
DK |
|
Zinnwald Lithium PLC
F:7WW
|
UK |
|
Alta Copper Corp
F:8BF
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1R7's stock price target?
Not Available
1R7 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Ronshine China Holdings Ltd?
Projected CAGR
65%
Over the last 12 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 4 years is 65%.